Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models.

[1]  M. Post,et al.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. , 1999, Circulation.

[2]  J. Isner,et al.  Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. , 1999, Journal of the American College of Cardiology.

[3]  M. Leon,et al.  Electromechanical characterization of myocardial hibernation in a pig model. , 1999, Coronary artery disease.

[4]  J. Isner,et al.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.

[5]  M. Leon,et al.  Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability. , 1998, Circulation.

[6]  M. Leon,et al.  Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. , 1998, Circulation.

[7]  B. V. von Specht,et al.  Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. , 1998, Circulation.

[8]  R. Crystal,et al.  Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. , 1998, The Journal of thoracic and cardiovascular surgery.

[9]  M. Leon,et al.  Feasibility and safety of percutaneous laser revascularization using the BiosenseTM system in porcine hearts , 1998, Coronary artery disease.

[10]  J. Waltenberger.  Modulation of growth factor action: implications for the treatment of cardiovascular diseases. , 1997, Circulation.

[11]  D. Dadhania,et al.  Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. , 1997, Cardiovascular research.

[12]  L. Gepstein,et al.  A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. , 1997, Circulation.

[13]  Mark E. Josephson,et al.  Nonfluoroscopic, in vivo navigation and mapping technology , 1996, Nature Medicine.

[14]  S. Epstein,et al.  Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. , 1996, Circulation.

[15]  Peipei Ping,et al.  Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heart , 1996, Nature Medicine.

[16]  A. Takeshita,et al.  Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. , 1995, Cardiovascular research.

[17]  S. Vatner,et al.  Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? , 1995, Circulation research.

[18]  S. Epstein,et al.  Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. , 1995, Circulation.

[19]  S. Epstein,et al.  Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. , 1994, Circulation.

[20]  S. Epstein,et al.  Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. , 1994, The American journal of physiology.

[21]  R. Crystal,et al.  Efficient gene transfer into myocardium by direct injection of adenovirus vectors. , 1993, Circulation research.